Matrixx Launches Zicam Products To Rebound During Cold Season
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives says after weathering the storm of recalling two Zicam OTC homeopathic intranasal zinc-containing cold products, the firm's "real test" will come when the cold season reveals whether customers switch to oral delivery products
You may also be interested in...
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.